SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-164675
Filing Date
2023-06-12
Accepted
2023-06-09 21:39:27
Documents
11
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 6-K d510614d6k.htm 6-K 13058
2 EX-1.1 d510614dex11.htm EX-1.1 249509
3 EX-99.1 d510614dex991.htm EX-99.1 138088
4 GRAPHIC g510614g0609181239226.jpg GRAPHIC 17408
5 GRAPHIC g510614g0609181239414.jpg GRAPHIC 23796
6 GRAPHIC g510614g0609181239539.jpg GRAPHIC 20589
7 GRAPHIC g510614g0609181239648.jpg GRAPHIC 12385
8 GRAPHIC g510614g0609181239757.jpg GRAPHIC 10825
9 GRAPHIC g510614g0609181239867.jpg GRAPHIC 18274
10 GRAPHIC g510614g0609181239992.jpg GRAPHIC 8654
11 GRAPHIC g510614g0609181240101.jpg GRAPHIC 10833
  Complete submission text file 0001193125-23-164675.txt   572079
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41562 | Film No.: 231006963
SIC: 2834 Pharmaceutical Preparations